IL1B and Alzheimer disease: High molecular weight water‐soluble chitosan (WSC) has been shown to inhibit the production of pro‐inflammatory cytokines in an in vitro model for AD of human astrocytoma cells activated by Aβ peptide 25–35 (Aβ25–35) and interleukin‐1 beta (IL‐1β).